India  
 
NewsR.in

U.S. pays Pfizer, BioNTech $2 bln for vaccines

Video Credit: Reuters Studio - Duration: 01:15s - Published
U.S. pays Pfizer, BioNTech $2 bln for vaccines

U.S. pays Pfizer, BioNTech $2 bln for vaccines

The U.S. government will pay $1.95 billion to buy 100 million doses of Pfizer's and German biotech firm BioNTech's COVID-19 vaccine candidate if they are able to successfully develop one, the companies said on Wednesday.

Fred Katayama reports.


You Might Like

Related news from verified sources

Britain signs deals with Pfizer, BioNTech, Valneva for COVID-19 vaccines

Britain has signed deals to secure 90 million doses of two possible COVID-19 vaccines from the Pfizer...
Hindu - Published


Related videos from verified sources

U.S. to pay Sanofi, GSK $2.1 bln for vaccines [Video]

U.S. to pay Sanofi, GSK $2.1 bln for vaccines

Washington is to pay European drug giants Sanofi and GSK 2.1 billion dollars to cover vaccines for 50 million people. Julian Satterthwaite reports.

Credit: Reuters Studio     Duration: 01:20Published
US to Pay Pfizer and BioNTech $2B for 100 Million Doses of COVID-19 Vaccine [Video]

US to Pay Pfizer and BioNTech $2B for 100 Million Doses of COVID-19 Vaccine

The deal was announced on Wednesday.

Credit: Cover Video STUDIO     Duration: 01:11Published
UK Orders 90 Million COVID-19 Vaccine Doses from Pfizer and Valneva [Video]

UK Orders 90 Million COVID-19 Vaccine Doses from Pfizer and Valneva

The United Kingdom will receive 30 million doses of Pfizer and BioNTech's vaccine candidate, making it the partnership's first agreement with any government.

Credit: Cover Video STUDIO     Duration: 01:05Published